{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:05Z","timestamp":1791928685474,"version":"4.3.4"},"reference-count":50,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,9,25]]},"DOI":"10.1167\/iovs.18-23994","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T03:42:11Z","timestamp":1538192531000},"page":"4701","source":"Crossref","is-referenced-by-count":31,"title":["Pathophysiological Role of VEGF on Retinal Edema and Nonperfused Areas in Mouse Eyes With Retinal Vein Occlusion"],"prefix":"10.1167","volume":"59","author":[{"given":"Anri","family":"Nishinaka","sequence":"first","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Inoue","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Fuma","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Hida","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-11-4701-b01","doi-asserted-by":"crossref","unstructured":"Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010; 117: 313\u2013319.e1.","DOI":"10.1016\/j.ophtha.2009.07.017"},{"key":"i1552-5783-59-11-4701-b02","doi-asserted-by":"crossref","unstructured":"Bunce, C, Xing W, Wormald, R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond). 2010; 24: 1692\u20131699.","DOI":"10.1038\/eye.2010.122"},{"key":"i1552-5783-59-11-4701-b03","unstructured":"Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995; 72: 638\u2013645."},{"key":"i1552-5783-59-11-4701-b04","doi-asserted-by":"crossref","unstructured":"Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005; 140: 256\u2013261.","DOI":"10.1016\/j.ajo.2005.03.003"},{"key":"i1552-5783-59-11-4701-b05","doi-asserted-by":"crossref","unstructured":"Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995; 1: 1024\u20131028.","DOI":"10.1038\/nm1095-1024"},{"key":"i1552-5783-59-11-4701-b06","unstructured":"Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995; 146: 1029\u20131039."},{"key":"i1552-5783-59-11-4701-b07","doi-asserted-by":"crossref","unstructured":"Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. 1997; 46: 1473\u20131480.","DOI":"10.2337\/diab.46.9.1473"},{"key":"i1552-5783-59-11-4701-b08","doi-asserted-by":"crossref","unstructured":"Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005; 25: 111\u2013118.","DOI":"10.1097\/00006982-200502000-00001"},{"key":"i1552-5783-59-11-4701-b09","doi-asserted-by":"crossref","unstructured":"Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. V. Retinal telangiectasis. Arch Ophthalmol. 1968; 80: 592\u2013605.","DOI":"10.1001\/archopht.1968.00980050594005"},{"key":"i1552-5783-59-11-4701-b10","doi-asserted-by":"crossref","unstructured":"Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 1992; 110: 1427\u20131434.","DOI":"10.1001\/archopht.1992.01080220089028"},{"key":"i1552-5783-59-11-4701-b11","doi-asserted-by":"crossref","unstructured":"Murakami T, Tsujikawa A, Miyamoto K, et al. Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusion. Eye (Lond). 2012; 26: 771\u2013780.","DOI":"10.1038\/eye.2012.85"},{"key":"i1552-5783-59-11-4701-b12","doi-asserted-by":"crossref","unstructured":"Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010; 117: 1102\u20131112.e1.","DOI":"10.1016\/j.ophtha.2010.02.021"},{"key":"i1552-5783-59-11-4701-b13","doi-asserted-by":"crossref","unstructured":"Brown DM, Campochiaro PA, Bhisitku RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011; 118: 1594\u20131602.","DOI":"10.1016\/j.ophtha.2011.02.022"},{"key":"i1552-5783-59-11-4701-b14","doi-asserted-by":"crossref","unstructured":"Thach AB, Yau L, Hoang C, Tuomi L. Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials. Ophthalmology. 2014; 121: 1059\u20131066.","DOI":"10.1016\/j.ophtha.2013.11.022"},{"key":"i1552-5783-59-11-4701-b15","doi-asserted-by":"crossref","unstructured":"Mir TA, Kherani S, Hafiz G, et al. Changes in retinal nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion. Ophthalmology. 2016; 123: 625\u2013634.e1.","DOI":"10.1016\/j.ophtha.2015.10.030"},{"key":"i1552-5783-59-11-4701-b16","doi-asserted-by":"crossref","unstructured":"Isola V, Pece A, Massironi C, Reposi S, Dimastrogiovanni F. Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients. Clin Ophthalmol. 2013; 7: 455\u2013460.","DOI":"10.2147\/OPTH.S30156"},{"key":"i1552-5783-59-11-4701-b17","doi-asserted-by":"crossref","unstructured":"Sophie R, Hafiz G, Scott AW, et al. Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion. Am J Ophthalmol. 2013; 156: 693\u2013705.","DOI":"10.1016\/j.ajo.2013.05.039"},{"key":"i1552-5783-59-11-4701-b18","doi-asserted-by":"crossref","unstructured":"Fuma S, Nishinaka A, Inoue YA, et al pharmacological approach in newly established retinal vein occlusion model. Sci Rep. 2017; 7: 43509.","DOI":"10.1038\/srep43509"},{"key":"i1552-5783-59-11-4701-b19","doi-asserted-by":"crossref","unstructured":"Narimatsu T, Ozawa Y, Miyake S, et al. Disruption of cell-cell junctions and induction of pathological cytokines in the retinal pigment epithelium of light-exposed mice. Invest Ophthalmol Vis Sci. 2013; 54: 4555\u20134562.","DOI":"10.1167\/iovs.12-11572"},{"key":"i1552-5783-59-11-4701-b20","doi-asserted-by":"crossref","unstructured":"Cachafeiro M, Bemelmans AP, Samardzija M, et al. Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability. Cell Death Dis. 2013; 4: e781.","DOI":"10.1038\/cddis.2013.303"},{"key":"i1552-5783-59-11-4701-b21","doi-asserted-by":"crossref","unstructured":"Nakahara T, Hoshino M, Hoshino S, Mori A, Sakamoto K, Ishii K. Structural and functional changes in retinal vasculature induced by retinal ischemia-reperfusion in rats. Exp Eye Res. 2015; 135: 134\u2013145.","DOI":"10.1016\/j.exer.2015.02.020"},{"key":"i1552-5783-59-11-4701-b22","doi-asserted-by":"crossref","unstructured":"Ogishima H, Nakamura S, Nakanishi T, et al. Ligation of the pterygopalatine and external carotid arteries induces ischemic damage in the murine retina. Invest Ophthalmol Vis Sci. 2011; 52: 9710\u20139720.","DOI":"10.1167\/iovs.11-8160"},{"key":"i1552-5783-59-11-4701-b23","doi-asserted-by":"crossref","unstructured":"Wang L, Cull GA, Piper C, Burgoyne CF, Fortune B. Anterior and posterior optic nerve head blood flow in nonhuman primate experimental glaucoma model measured by laser speckle imaging technique and microsphere method. Invest Ophthalmol Vis Sci. 2012; 53: 8303\u20138309.","DOI":"10.1167\/iovs.12-10911"},{"key":"i1552-5783-59-11-4701-b24","doi-asserted-by":"crossref","unstructured":"Suzuma K, Takagi H, Otani A, Suzuma I, Honda Y. Increased expression of KDR\/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc Res. 1998; 56: 183\u2013191.","DOI":"10.1006\/mvre.1998.2111"},{"key":"i1552-5783-59-11-4701-b25","doi-asserted-by":"crossref","unstructured":"Kanellis J, Paizis K, Cox AJ, et al. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression. Kidney Int. 2002; 61: 1696\u20131706.","DOI":"10.1046\/j.1523-1755.2002.00329.x"},{"key":"i1552-5783-59-11-4701-b26","doi-asserted-by":"crossref","unstructured":"Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998; 274: H1054\u2013H1058.","DOI":"10.1152\/ajpheart.1998.274.3.H1054"},{"key":"i1552-5783-59-11-4701-b27","doi-asserted-by":"crossref","unstructured":"Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002; 90: 1243\u20131250.","DOI":"10.1161\/01.RES.0000022200.71892.9F"},{"key":"i1552-5783-59-11-4701-b28","unstructured":"Ozaki H, Yu AY, Della N, Ozaki K, et al. Hypoxia inducible factor-1 alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1999; 40: 182\u2013189."},{"key":"i1552-5783-59-11-4701-b29","doi-asserted-by":"crossref","unstructured":"Wong D, Dorovini-Zis K. Upregulation of intercellular adhesion molecular-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol. 1992; 39: 11\u201321.","DOI":"10.1016\/0165-5728(92)90170-P"},{"key":"i1552-5783-59-11-4701-b30","doi-asserted-by":"crossref","unstructured":"Argaw AT, Asp L, Zhang J, et al. Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest. 2012; 122: 2454\u20132468.","DOI":"10.1172\/JCI60842"},{"key":"i1552-5783-59-11-4701-b31","doi-asserted-by":"crossref","unstructured":"Campochiaro PA, Wykoff CC, Shapiro H, Rubio RG, Ehrlich JS. Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. Ophthalmology. 2014; 121: 1783\u20131789.","DOI":"10.1016\/j.ophtha.2014.03.021"},{"key":"i1552-5783-59-11-4701-b32","doi-asserted-by":"crossref","unstructured":"Kida T, Oku H, Horie T, et al. Implication of VEGF and aquaporin 4 mediating Muller cell swelling to diabetic retinal edema. Graefes Arch Clin Exp Ophthalmol. 2017; 255: 1149\u20131157.","DOI":"10.1007\/s00417-017-3631-z"},{"key":"i1552-5783-59-11-4701-b33","unstructured":"Sakamoto T, Sakamoto H, Sheu SJ, Gabrielian K, Ryan SJ, Hinton DR. Intercellular gap formation induced by thrombin in confluent cultured bovine retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1994; 35: 720\u2013729."},{"key":"i1552-5783-59-11-4701-b34","doi-asserted-by":"crossref","unstructured":"Weidemann A, Krohne TU, Aguilar E, et al. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia. 2010; 58: 1177\u20131185.","DOI":"10.1002\/glia.20997"},{"key":"i1552-5783-59-11-4701-b35","doi-asserted-by":"crossref","unstructured":"MacVicar BA, Newman EA. Astrocyte regulation of blood flow in the brain. Cold Spring Harb Perspect Biol. 2015; 7: a020388.","DOI":"10.1101\/cshperspect.a020388"},{"key":"i1552-5783-59-11-4701-b36","doi-asserted-by":"crossref","unstructured":"Bernatchez PN, Soker S, Sirois MG. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem. 1999; 274: 31047\u201331054.","DOI":"10.1074\/jbc.274.43.31047"},{"key":"i1552-5783-59-11-4701-b37","unstructured":"Kupferschmid S. Does VEGF promote proliferation of non-perfused retinal areas? [in German]. Klin Monbl Augenheilkd. 2013; 230: 1078\u20131080."},{"key":"i1552-5783-59-11-4701-b38","doi-asserted-by":"crossref","unstructured":"Niki T, Muraoka K, Shimizu K. Distribution of capillary nonperfusion in early-stage diabetic retinopathy. Ophthalmology. 1984; 91: 1431\u20131439.","DOI":"10.1016\/S0161-6420(84)34126-4"},{"key":"i1552-5783-59-11-4701-b39","doi-asserted-by":"crossref","unstructured":"Abri Aghdam K, Reznicek L, Soltan Sanjari M, Klingenstein A, Kernt M, Seidensticker F. Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion. Clin Ophthalmol. 2017; 11: 331\u2013336.","DOI":"10.2147\/OPTH.S125486"},{"key":"i1552-5783-59-11-4701-b40","doi-asserted-by":"crossref","unstructured":"Tsuboi K, Ishida Y, Kamei M. Gap in capillary perfusion on optical coherence tomography angiography associated with persistent macular edema in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2017; 58: 2038\u20132043.","DOI":"10.1167\/iovs.17-21447"},{"key":"i1552-5783-59-11-4701-b41","doi-asserted-by":"crossref","unstructured":"Plate KH, Beck H, Danner S, Allegrini PR, Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J Neuropathol Exp Neurol. 1999; 58: 654\u2013666.","DOI":"10.1097\/00005072-199906000-00010"},{"key":"i1552-5783-59-11-4701-b42","doi-asserted-by":"crossref","unstructured":"Verkman AS, Phuan PW, Asavapanumas N, Tradtrantip L. Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol. 2013; 23: 684\u2013695.","DOI":"10.1111\/bpa.12085"},{"key":"i1552-5783-59-11-4701-b43","doi-asserted-by":"crossref","unstructured":"Filippidis AS, Carozza RB, Rekate HL. Aquaporins in brain edema and neuropathological conditions. Int J Mol Sci. 2016; 18: E55.","DOI":"10.3390\/ijms18010055"},{"key":"i1552-5783-59-11-4701-b44","doi-asserted-by":"crossref","unstructured":"Chu H, Tang Y, Dong Q. Protection of vascular endothelial growth factor to brain edema following intracerebral hemorrhage and its involved mechanisms: effect of aquaporin-4. PLoS One. 2013; 8: e66051.","DOI":"10.1371\/journal.pone.0066051"},{"key":"i1552-5783-59-11-4701-b45","doi-asserted-by":"crossref","unstructured":"Narasimhan P, Liu J, Song YS, Massengale JL, Chan PH. VEGF Stimulates the ERK 1\/2 signaling pathway and apoptosis in cerebral endothelial cells after ischemic conditions. Stroke. 2009; 40: 1467\u20131473.","DOI":"10.1161\/STROKEAHA.108.534644"},{"key":"i1552-5783-59-11-4701-b46","doi-asserted-by":"crossref","unstructured":"Sun D, Nakao S, Xie F, et al. Molecular imaging reveals elevated VEGFR-2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis. FASEB J. 2014; 28: 3942\u20133951.","DOI":"10.1096\/fj.14-251934"},{"key":"i1552-5783-59-11-4701-b47","doi-asserted-by":"crossref","unstructured":"Muthusamy A, Lin CM, Shanmugam S, Lindner HM, Abcouwer SF, Antonetti DA. Ischemia-reperfusion injury induces occluding phosphorylation\/ubiquitination and retinal vascular permeability in a VEGF-R2-dependent manner. J Cereb Blood Flow Metab. 2014; 34: 522\u2013531.","DOI":"10.1038\/jcbfm.2013.230"},{"key":"i1552-5783-59-11-4701-b48","doi-asserted-by":"crossref","unstructured":"Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003; 111: 1843\u20131851.","DOI":"10.1172\/JCI200317977"},{"key":"i1552-5783-59-11-4701-b49","doi-asserted-by":"crossref","unstructured":"Sarantos MR, Papanikolaou T, Ellerby LM, Hughes RE. Pizotifen activates ERK and provides neuroprotection in vitro and in vivo in models of Huntington's disease. J Huntingtons Dis. 2012; 1: 195\u2013210.","DOI":"10.3233\/JHD-120033"},{"key":"i1552-5783-59-11-4701-b50","doi-asserted-by":"crossref","unstructured":"Korn C, Augustin HG. Mechanisms of vessel pruning and regression. Dev Cell. 2015; 34: 5\u201317.","DOI":"10.1016\/j.devcel.2015.06.004"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2704875","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:57Z","timestamp":1791927057000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-23994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,9,4]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-23994","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,25]]}}}